Javier Morales|Doron Schneider
Hypoglycemia
Advanced Pharma
hypoglycemia common potentially avoidable consequence diabetes treatment major barrier initiating intensifying antihyperglycemic therapy efforts achieve better glycemic control therapy regimen history hypoglycemia important predictors future events risk factors include renal insufficiency older age history hypoglycemiaassociated autonomic failure reported rates hypoglycemia vary considerably among studies differences study design definitions used population included among factors although occurring frequently type 1 diabetes hypoglycemia also clinically important type 2 diabetes symptoms experienced patients vary among individuals many events remain undiagnosed incidence severe events unevenly distributed small proportion 5 individuals accounting 50 events consequently clinicians must conscientious obtaining thorough patient histories accurate picture frequency severity hypoglycemic events essential optimal diabetes management severe hypoglycemia particular associated increased risk mortality impairments cognitive function adverse effects patients quality life economically hypoglycemia burdens healthcare system adversely affects workplace productivity particularly nocturnal event ongoing healthcare reform efforts result even emphasis reducing side effect diabetes treatment therefore improving patients selfmanagement skills selecting modifying therapy reduce risk hypoglycemia increase importance clinicians patients alike